News | News By Subject | News by Disease News By Date | Search News

Pain control News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug     3/21/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome     1/18/2017
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA     12/30/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
Gilead (GILD) Might Avoid Fighting Celgene (CELG), But Allergan (AGN), Intercept Pharma (ICPT) and Novartis AG (NVS) Await     10/4/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters     9/6/2016
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint     8/15/2016
Endo International (ENDP) Withdraws Its Supplemental NDA for Pain Drug OPANA     8/12/2016
Recro Pharma (REPH) Shares Rocket as Intravenous Painkiller Succeeds in Phase III Trial     7/27/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application     6/14/2016
Innocoll (INNL)'s Painkiller Passes Final Phase III Tests, Heads for 2017 Launch     5/25/2016
Sanofi (SNY) Recalls Some Batches of Combiflam in India     5/12/2016

News from Around the Web
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio     2/10/2017
University of Pennsylvania Should Rethink Over-Hyped Press Releases     1/11/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
New Compound May Treat Pain Without Opioid- Or Marijuana-Use Side Effects, Indiana University Study     11/15/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
Can A "Smart" Pain Management System Be Alternative To Opioids For Chronic Pain?     11/4/2016
Specialists Alarmed About Children Prescribed Opium-Derived Painkillers     10/31/2016
"Fake Pills" May Help Ease Back Pain, Beth Israel Deaconess Medical Center Study     10/21/2016
New Opioids Could Relieve Pain Without Dangerous Side Effects, UCSF Study     10/17/2016
Why Does My Pain Come And Go?     10/6/2016
An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain     10/5/2016
Artificial Knee Implant Provides New Treatment Options For Joint Pain     9/30/2016
For Pain Therapeutics (PTIE) CEO, 3 FDA Rejections Are Worth $23 Million     9/27/2016
UVLrx Therapy Lights Up Charlatans Dealing In Medical Devices, UVLrx Therapeutics Reveals     9/26/2016
Wet Weather And No Sun Really Does Make Chronic Pain Worse, University of Manchester Study     9/7/2016

Press Releases
Shionogi Release: FDA Approves Symproic (Naldemedine) Once-Daily Tablets C-II For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain     3/24/2017
New Data Presented On Adapt Pharma's Community Use Of Narcan Nasal Spray 4 Mg To Reverse Opioid-Related Overdose     3/17/2017
American Academy Of Pain Medicine Release: Stem Cell Transplantation Produces Remarkable Therapeutic Effects On Neuropathic Pain In Animal Models     3/17/2017
Centrexion To Present Late-Breaking Poster At The 33rd Annual American Academy Of Pain Medicine Meeting     3/16/2017
A Published Peer-Reviewed Case Study Supports Use Of Proove Biosciences Precision Medicine Technology In Post-Operative Pain     3/15/2017
Heptares Enters Agreement With Daiichi Sankyo To Discover And Develop Novel, Small-Molecules For The Treatment Of Pain     3/13/2017
Elite Pharma (ELI) Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx     3/13/2017
CerSci Therapeutics Awarded $225K Phase I NIH SBIR Grant For The Treatment Of Neuropathic Pain     3/8/2017
SCYNEXIS, Inc. (SCYX) Delays Initiation Of New Clinical Studies Using The IV Formulation Of SCY-078 At FDA’s Request     3/3/2017
Adynxx Initiates ADYX-004, A Phase II Study Of AYX1, Lead Compound For The Treatment Of Post-Surgical Pain     3/1/2017
AcelRx (ACRX)' New Drug Application For DSUVIA Accepted For Filing With PDUFA Date Of October 12, 2017     2/27/2017
Recro Pharma (REPH) Completes Enrollment In Phase III Safety Study Of IV Meloxicam     2/27/2017
Ampio Pharmaceuticals, Inc. (AMPE) Receives Guidance From The FDA And Proposes A Path For Approval For Single-Injection Ampion For The Treatment Of Pain Due To Severe Osteoarthritis Of The Knee     2/27/2017
Courtagen Receives Notice Of Allowance For A Genetically Targeted Pain Therapy Patent In The U.S.     2/23/2017
Kineta Release: KCP-400 Relieves Chronic Pain And Demonstrates Disease Modifying Effects     2/22/2017

//-->